GNK Holdings LLC criticized BARK, Inc.'s board for rejecting its $22 per share all-cash acquisition proposal, which was a 22% premium over a prior offer. Since the rejection, BARK's stock price has fallen about 58% to $9.19 per share, far below GNK's offer. GNK argues the board's decision has destroyed shareholder value and demands accountability and a clear plan to restore value. GNK remains interested in BARK and plans to explore options to protect its investment and advocate for shareholders.
GNK Holdings' call for accountability at BARK comes as the Consumer Cyclical sector on Pluang shows a broad decline, with 69 of 105 US stocks falling today. For readers following this sector, here is Pluang's market snapshot as of Sep 15, 2026 20:04 WIB: XPEV (Xpeng Inc - ADR) traded at USD 10.39, down 2.99%, LI (Li Auto Inc) at USD 11.88, down 2.38%, and APTV (Aptiv PLC) at USD 43.84, down 2.11%.
Ascendis Pharma A/S regained full control of its TransCon technology for metabolic diseases from Novo Nordisk, allowing it to independently develop and sell treatments, including for obesity. The company also authorized a $400 million share repurchas...
Deutsche Bank upgraded AstraZeneca's stock rating from Sell to Hold following mixed results from its drug trials. The lung disease drug tozorakimab showed strong Phase III results and received FDA priority review, signaling potential future growth. H...
Tesla's US market share has recovered to 52% after a sharp decline in 2025 linked to CEO Elon Musk's political ties, which hurt brand loyalty and wiped out over $500 billion in market value. While overall US EV sales dropped 30% through August 2026, ...
Oracle's stock has fallen over 52% in the past year but is expected to recover strongly, with Mizuho Securities predicting a 121% rise to $320 in the next 12 months. This optimism is driven by accelerating cloud infrastructure growth and disciplined ...
Elon Musk and Jim Cramer both suspect that AI doom warnings from leading labs are motivated by commercial interests. Musk proposes a peer-review safety system where AI companies test each other's models to prevent harmful behavior, emphasizing the ne...
